We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Changes Fees for Variations to Marketing Authorizations
EMEA Changes Fees for Variations to Marketing Authorizations
January 14, 2010
The European Medicines Agency (EMEA) has updated its fees for 2010 and applicants are now able to group multiple changes to a marketing authorization into a single application and probably save money. Includes the full text of EMEA Explanatory Note on Marketing Authorization Fee.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor